Skip to main content

Table 2 The comparison of ovarian stimulation cycle outcomes between two groups

From: Adding L-carnitine to antagonist ovarian stimulation doesn’t improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: a double-blind randomized clinical trial

Variable

L-carnitine group

n = 47

Placebo group

n = 50

p-value*

Estradiol level on oocyte trigger day (pg/ml)

2625.7 (1363.1)

2536.4 (1410.1)

0.75

Total no. of used gonadotropin ampules

21.8 (7.6)

21.2 (8.1)

0.72

Stimulation duration (day)

10.2 (2.1)

9.9 (1.9)

0.48

Antagonist duration (day)

4.4 (1.2)

4.1 (1.0)

0.30

Total no. of observed follicles on oocyte trigger day

16.5 (6.2)

16.5 (5.0)

0.96

No. of follicles > 18 mm on oocyte trigger day

2.7 (1.7)

2.1 (1.5)

0.09

No. of retrieved oocytes

12.4 (6.2)

11.6 (4.7)

0.49

No. of MII oocytes

10.5 (4.6)

9.9 (4.7)

0.53

Oocyte maturity rate

0.86 (0.13)

0.83 (0.19)

0.44

Oocyte recovery ratio

0.63 (0.18)

0.59 (0.20)

0.23

Fertilization rate

0.70 (0.23)

0.73 (0.23)

0.37

Endometrium thickness on oocyte trigger day (cm)

10.0 (1.9)

9.5 (1.5)

0.10

All-freeze cases

40 (85.1)

41 (82)

0.68

Total no. of obtained embryos

9.9 (6.2)

10.2 (6.8)

0.77

No. of top-quality embryos

6.1 (6.0)

5.0 (4.7)

0.31

No. of frozen embryos (cleavage stage)

8.0 (6.1)

7.9 (5.8)

0.89

  1. Values are presented as the mean ± Standard deviation (SD) and number (percent). * Obtained by independent t test and chi square test. Statistically significant level was 0.05. MII metaphase II; No. number